Akita myocytes perfused with mexiletine. Upper panels: Representative action potential traces recorded from Ins2
Supplementary Figure 2. APD measured without 4-AP (see
). Ventricular myocytes were prepared from diabetic Ins2 Akita (Akita) and db/db mice or normoglycemic wild-type (WT) mice. Action potentials were recorded in the absence of 4-AP with or without intracellular infusion of 1 μM phospholipids or after a 2 h preincubation with 4 μg/ml mexiletine. Summary data of APD 90 are shown as mean ± SE. The number of cells studied is above each bar. Supplementary Figure 3 . Nav1.5, PDK1 and PTEN expression levels. (A) Heart membrane preparations from db/db, Ins2
Akita (Akita) and wild-type (WT) mice were analyzed by western blotting with an Nav1.5 antibody. The blot was reprobed with an HSP90 antibody as a loading control. (B) Total heart lysates were analyzed by western blotting with the indicated antibodies. Supplementary Figure 4 . Bazett heart rate correction of QT intervals measured in Fig. 3A & B. Cardiac electrical activity was recorded from spontaneously beating hearts mounted on a Langendorff apparatus. QT intervals corrected for heart rate (QTc) were calculated from the tracings using the Bazett formula (15). Summary QTc graphs show mean ± SE. (A) Akita and wild-type (WT) hearts were treated with insulin (1 unit/L), PI-103 (500 nM) or mexiletine (4 μg/mL) added to the perfusate. N ≥ 4 hearts per group. (B) db/db hearts before and after mexiletine treatment. N = 5 hearts.
Supplementary Figure 5. Expression of CAp110α in cultured Ins2
Akita (A) and db/db (B) myocytes. Myocytes were infected with adenoviruses carrying HA-tagged CAp110α or GFP as a control. Cells were harvested 48 h later and lysates were analyzed by western blotting using the indicated antibodies.
